Company intelligence / Profile preview

Cilo Cybin Pharmaceutical

Ownership: Private
Development stage: Commercial

Overview

Cilo Cybin is the first fully vertically integrated medical cannabis company in South Africa with both cultivation and manufacturing licenses. They produce GMP-certified cannabis products that are accepted by international regulatory authorities.

Therapeutic areas: PsychiatryNeurology
Modalities: Cannabis-derived productsMedical cannabis
Industry: Biotech

Drug pipeline

2 assets

cannabidiol

Commercial

Indications: Pain, Inflammation

1 more asset in the full pipeline.

Request access →

Partnerships

ALPS (clinical trial and genomics company)

Beyond the preview

Go deeper on Cilo Cybin Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cilo Cybin Pharmaceutical.

Explore the full profile